Can I prescribe cefixime and azithromycin to patients with chronic kidney disease, and what renal dose adjustments are required?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Prescribe Cefixime and Azithromycin to Patients with CKD?

Yes, both cefixime and azithromycin can be prescribed to patients with chronic kidney disease, but cefixime requires dose adjustment based on creatinine clearance, while azithromycin does not require any renal dose modification.

Cefixime Dosing in CKD

Cefixime requires dose reduction when creatinine clearance falls below 60 mL/min 1. The FDA-approved dosing adjustments are:

  • CrCl ≥60 mL/min: Normal dose (400 mg daily)
  • CrCl 21-59 mL/min (or hemodialysis): Reduce to approximately 260 mg daily (13 mL of 100 mg/5 mL suspension or 6.5 mL of 200 mg/5 mL suspension)
  • CrCl ≤20 mL/min (or continuous peritoneal dialysis): Reduce to approximately 172 mg daily (8.6 mL of 100 mg/5 mL suspension or 4.4 mL of 200 mg/5 mL suspension)

Key Points for Cefixime:

  • Neither hemodialysis nor peritoneal dialysis removes significant amounts of cefixime from the body 1, 2
  • No supplemental dosing is needed after dialysis
  • The elimination half-life increases from 3.7 hours in normal renal function to 11-14 hours in severe renal impairment 2, 3
  • Urinary concentrations remain above MIC for most urinary pathogens even in severe renal insufficiency 2

Azithromycin Dosing in CKD

Azithromycin requires NO dose adjustment in any stage of CKD, including end-stage renal disease 4. This is because:

  • The area under the curve (AUC), maximum plasma concentration, and volume of distribution remain unchanged regardless of renal function 4
  • Azithromycin has predominantly non-renal clearance
  • The same dosing regimen used in patients with normal renal function should be maintained in patients with renal impairment 4

Clinical Considerations

Common Pitfalls to Avoid:

  1. Don't forget to adjust cefixime doses: Studies show that cephalosporins are among the most commonly inappropriately dosed antibiotics in CKD patients, with antibiotics accounting for 77% of all inappropriate dose-adjustment events 5

  2. Calculate creatinine clearance accurately: Use the Cockcroft-Gault equation or CKD-EPI equation for dose adjustments, as these are what drug dosing recommendations are based on 6, 7

  3. Monitor for nephrotoxicity: While azithromycin is safe, be cautious about combining multiple potentially nephrotoxic agents 6

  4. Avoid nephrotoxic combinations: The KDOQI guidelines specifically warn against using aminoglycosides and NSAIDs in advanced CKD 6

Practical Algorithm:

  1. Determine CrCl using Cockcroft-Gault or obtain eGFR
  2. For cefixime:
    • CrCl ≥60: Use standard 400 mg daily
    • CrCl 21-59: Reduce to ~260 mg daily
    • CrCl ≤20: Reduce to ~172 mg daily
  3. For azithromycin: Use standard dosing (500 mg day 1, then 250 mg daily for 4 days, or 1000 mg single dose depending on indication) regardless of renal function

Additional Safety Notes:

  • Both drugs can be used safely in CKD when dosed appropriately 6, 8
  • Macrolides (including azithromycin) are generally listed as requiring 50% dose reduction only when CrCl <30 mL/min in some general guidelines 6, but specific pharmacokinetic studies of azithromycin show no adjustment is needed 4
  • Always review the patient's complete medication list for potential drug interactions and cumulative nephrotoxic burden 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.